This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Health Stock Winners and Losers: Glaxo

Updated from 3:16 p.m. EDT

Buoyed by the idea that swine flu fears could at least temporarily boost sales at some firms, health care stocks were largely in the green Monday.

GlaxoSmithKline (GSK), which makes antiviral drug Relenza, was among the day's early winners. The company, which issued a press release Monday that said it had sent Mexican officials 100,000 packs of Relenza and 170,000 additional doses of its seasonal flu vaccine, is "urgently assessing" ways to increase production of Relenza. Shares of the company rose 7.6% to $31.56. Novavax (NVAX), which owns technology for creating vaccines, rose 79.6% to $2.55.

Swine Flu Outbreak

Pfizer (PFE) shares rose 2.4% to $13.49 a day before the company's quarterly earnings report. Analysts expect the Lipitor maker, which is buying Wyeth (WYE), to report earnings of 49 cents on $11.08 billion in revenue, according to Thomson One.

Bristol-Myers Squibb (BMY), which also reports earnings Tuesday, rose 2.2% to $20.54. Analysts polled by Thomson One expect the firm to earn 47 cents per share on $5.13 billion in revenue.

Elsewhere:

Eli Lilly (LLY) shares rose 0.4% to $33.13.

Johnson & Johnson (JNJ) fell 0.1% to $50.86.

Merck (MRK) was essentially flat at $23.44.

Novo Nordisk (NVO) fell 2.6% to $47.49. The company reports earnings Thursday.

Abbott Labs (ABT) rose 0.2% to $43.16.



Schering-Plough (SGP) rose 0.1% to $22.19.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,113.54 +61.81 0.36%
S&P 500 1,983.53 +9.90 0.50%
NASDAQ 4,456.0160 +31.3120 0.71%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs